Literature DB >> 7241892

Protein losses during peritoneal dialysis.

M J Blumenkrantz, G M Gahl, J D Kopple, A V Kamdar, M R Jones, M Kessel, J W Coburn.   

Abstract

The losses of protein into dialysate have been considered a major limitation of maintenance peritoneal dialysis. We, therefore, undertook a comprehensive evaluation of protein losses in 30 patients undergoing maintenance intermittent peritoneal dialysis (IPD), 12 patients undergoing acute IPD, and 8 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The weekly loss of protein based upon the usual treatments per week was relatively similar with the three modes of dialysis. Protein losses during repeated dialyses were similar for a given patient, but there was repeated dialyses were similar for a given patient, but there was marked interpatient variation. During maintenance IPD, protein loss was 12.9 +/- (SD) 4.4 g per 10 hours of dialysis; albumin loss was 8.5 g, and IgG loss was 1.3 g. Approximately 50% of the protein loss was from the ascitic fluid accumulated during the interdialytic interval, and concentrations of most proteins in the ascitic fluid correlated with their serum levels. Serum protein concentrations were in the low, normal range and did not change during dialysis. The development of peritonitis markedly increased protein losses. During acute IPD, 23.3 +/- 16.5 g of protein were lost per 36 hours of dialysis, lower losses than those previously reported. With CAPD, 8.8 +/- 1.7 g of protein were removed per 24 hours; also immunoglobulin losses correlated with their serum concentrations. The results of these studies suggest that, in the absence of peritonitis, dialysate protein losses do not appear to limit the usefulness of peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241892     DOI: 10.1038/ki.1981.57

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

Review 1.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

2.  The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

Authors:  Tetsu Akimoto; Kazuhiro Shiizaki; Taro Sugase; Yuko Watanabe; Hiromichi Yoshizawa; Naoko Otani; Akihiko Numata; Eri Takeshima; Tomoyuki Yamazaki; Takuya Miki; Chiharu Ito; Johanne V Pastor; Yoshitaka Iwazu; Osamu Saito; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

Review 3.  Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  E Keller; P Reetze; P Schollmeyer
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.

Authors:  Daisuke Takada; Akiko Mii; Seiichiro Higo; Yoshihiro Obara; Yuichi Kurabayashi; Norio Kurosawa; Shiro Miura; Hiroshi Kawachi; Akira Shimizu
Journal:  CEN Case Rep       Date:  2012-04-25

5.  Tolvaptan increases urine and ultrafiltration volume for patients with oliguria undergoing peritoneal dialysis.

Authors:  Tohru Iwahori; Masatoshi Esaki; Hayao Hinoue; Shinga Esaki; Yukumi Esaki
Journal:  Clin Exp Nephrol       Date:  2013-10-11       Impact factor: 2.801

Review 6.  Peritoneal dialysis for acute kidney injury.

Authors:  Brett Cullis; Mohamed Abdelraheem; Georgi Abrahams; Andre Balbi; Dinna N Cruz; Yaacov Frishberg; Vera Koch; Mignon McCulloch; Alp Numanoglu; Peter Nourse; Roberto Pecoits-Filho; Daniela Ponce; Bradley Warady; Karen Yeates; Fredric O Finkelstein
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

Review 7.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

8.  Metabolic implications of peritoneal dialysis in patients with acute kidney injury.

Authors:  Cassiana Regina Góes; Marina Nogueira Berbel; Andre Luis Balbi; Daniela Ponce
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

9.  Coagulation abnormalities in chronic peritoneal dialysis.

Authors:  C L Jones; M Andrew; A Eddy; M O'Neil; N I Shalom; J W Balfe
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

10.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.